Featured Research

from universities, journals, and other organizations

KISS1 Protein Required For Metastasis Suppression

Date:
February 22, 2007
Source:
Journal of the National Cancer Institute
Summary:
A new study finds that the secretion of a protein known as KISS1 reduces metastasis of cells that express it to multiple organs in mice, but the mechanism for this continues to elude researchers. The study appears in the Feb. 21 issue of the Journal of the National Cancer Institute.

A new study finds that the secretion of a protein known as KISS1 reduces metastasis of cells that express it to multiple organs in mice, but the mechanism for this continues to elude researchers. The study appears in the Feb. 21 issue of the Journal of the National Cancer Institute.

The KISS1 protein also plays a role in sexual maturation when it is secreted and then processed into smaller peptides called kisspeptins, which in turn bind to a receptor known as GPR54. Kevin Nash, Ph.D., in the laboratory of Danny R. Welch, Ph.D., of the University of Alabama at Birmingham, and their colleagues wondered if the GPR54 receptor was also involved in metastasis suppression.

Using a human melanoma cell line that could not express KISS1, the researchers inserted one of two forms of the KISS1 gene into the cells—coding for either an unaltered form of KISS1 or a version that could not be secreted. The cells were later injected into mice that were monitored for changes in survival rates and metastatic activity of the injected cells.

The researchers concluded that KISS1 secretion was required for metastasis suppression of the melanoma cells. Only the cells with the intact form of KISS1 secreted kisspeptins, and these cells showed less metastatic activity when they were injected into the mice than those with the altered version. Mice that were injected with the gene for the intact KISS1 protein lived much longer, on average, than the mice with the non-secretable KISS1 cells. Furthermore, KISS1 blocked the growth of tumor cells that have already spread other organs. But, the authors conclude, the GPR54 receptors did not likely play a role in this process.

“The finding that KISS1 can inhibit metastatic growth in multiple organs is a particularly important feature for an antimetastatic molecular agent,” the authors write. “Finally, the finding that KISS1 can suppress metastasis in the apparent absence of GPR54 in tumor cells opens up the possibility that additional KISS1 metastasis suppressor receptors and signaling pathways exist with the potential to be selectively targeted.”

Note: The Journal of the National Cancer Institute is published by Oxford University Press and is not affiliated with the National Cancer Institute. Visit the Journal online at http://jnci.oxfordjournals.org/.


Story Source:

The above story is based on materials provided by Journal of the National Cancer Institute. Note: Materials may be edited for content and length.


Cite This Page:

Journal of the National Cancer Institute. "KISS1 Protein Required For Metastasis Suppression." ScienceDaily. ScienceDaily, 22 February 2007. <www.sciencedaily.com/releases/2007/02/070221093015.htm>.
Journal of the National Cancer Institute. (2007, February 22). KISS1 Protein Required For Metastasis Suppression. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2007/02/070221093015.htm
Journal of the National Cancer Institute. "KISS1 Protein Required For Metastasis Suppression." ScienceDaily. www.sciencedaily.com/releases/2007/02/070221093015.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins